Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.20.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 2,377 $ 157
Cost of goods sold 3,884 34
Gross margin (1,507) 123
Operating expenses:    
Research and development 2,787 2,219
Selling and supply chain 1,580 904
General and administrative 4,720 4,162
Management fees 62 361
Total operating expenses 9,149 7,646
Loss from operations (10,656) (7,523)
Interest, net (398) 172
Foreign currency transaction loss (9) (24)
Loss before income taxes (11,063) (7,375)
Income taxes 0 0
Net loss $ (11,063) $ (7,375)
Basic and diluted loss per share $ (0.34) $ (0.23)
Weighted average shares outstanding - basic and diluted 32,988,141 32,677,944